摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-<4-<4-(phenylmethyl)piperazin-1-yl>phenyl>methanesulfonamide | 125818-95-3

中文名称
——
中文别名
——
英文名称
N-<4-<4-(phenylmethyl)piperazin-1-yl>phenyl>methanesulfonamide
英文别名
N-[4-[4-(phenylmethyl)piperazin-1-yl]phenyl]methanesulfonamide;N-[4-(4-benzylpiperazin-1-yl)phenyl]methanesulfonamide
N-<4-<4-(phenylmethyl)piperazin-1-yl>phenyl>methanesulfonamide化学式
CAS
125818-95-3
化学式
C18H23N3O2S
mdl
——
分子量
345.466
InChiKey
JRXBHEKTXCTCAQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    61
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-<4-<4-(phenylmethyl)piperazin-1-yl>phenyl>methanesulfonamide 生成 N-[4-(piperazin-1-yl)phenyl]methanesulfonamide
    参考文献:
    名称:
    LIS, RANDALL;MORGAN, THOMAS K. (JR);MARISCA, ANTHONY J.;GOMEZ, ROBERT P.;+, J. MED. CHEM., 33,(1990) N0, C. 2883-2891
    摘要:
    DOI:
  • 作为产物:
    描述:
    methanesulfonic anhydride 、 4-(4-苄基哌嗪)苯胺乙腈 为溶剂, 反应 5.0h, 生成 N-<4-<4-(phenylmethyl)piperazin-1-yl>phenyl>methanesulfonamide
    参考文献:
    名称:
    Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity
    摘要:
    Several (aryloxy)propanolamines and related compounds (i.e. 5-13, 16-18, 20-24, 27-33, 35, 37-39, 41, and 42) were synthesized and investigated for their class III electrophysiological activity and class II (beta-blocking) effects with use of in vitro and in vivo models. Structure-activity relationships are discussed for a series of 30 compounds. A number of these compounds prolonged the action potential duration at 95% repolarization of isolated canine cardiac Purkinje fibers by 20% (C20APD95) at concentrations of less than 1.0 microM, with no significant effects on cardiac conduction. beta-Adrenergic receptor binding studies showed that some of these compounds were 2-20 times more potent for cardiac beta 1 receptors than for beta 2 receptors. In particular, compounds 32, 41, 1, and especially (S)-1 were found to be orally active class III agents in anesthetized mongrel dogs (1 or 3 mg/kg, id) and efficacious at suppressing programmed electrical stimulation induced arrhythmias in halothane-anesthetized dogs. The profile of these compounds was similar to that found for sotalol. Compound (S)-1, which was more potent than sotalol in the PES study and equieffective in the halothane/epinephrine dog model, is being investigated further as a combined class III/II antiarrhythmic agent.
    DOI:
    10.1021/jm00172a033
点击查看最新优质反应信息

文献信息

  • Derivatized alkanolamines as cardiovascular agents
    申请人:Schering AG
    公开号:US05051423A1
    公开(公告)日:1991-09-24
    Novel derivatized alkanolamines of the following structural formula ##STR1## are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.
    以下结构式##STR1##的新型衍生烷醇胺被描述为有用的心血管药物。特别描述了它们作为表现出抗心律失常作用的心血管药物的有用性。所述的抗心律失常作用属于II类/III类结合型。还描述了含有这类化合物的药物配方。
  • Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as
    申请人:Schering A.G.
    公开号:US04906634A1
    公开(公告)日:1990-03-06
    Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents, especially as antiarrhythmic agents are described. Pharmaceutical formulations containing such compounds are also discussed.
    描述了新型N-[4-(氨基取代)苯基]甲磺酰胺类化合物及其作为心血管药物的用途,特别是作为抗心律失常药物的用途。还讨论了含有这类化合物的药物配方。
  • Novel-N-(4-(Aminosubstituted)phenyl) methanesulfonamides and their use as cardiovascular agents
    申请人:SCHERING AKTIENGESELLSCHAFT
    公开号:EP0332570A2
    公开(公告)日:1989-09-13
    Novel N-[4-aminosubstituted)phenyl]methane­sulfonamides and their use as cardiovascular agents, especially as antiarrhythmic agents are described. Pharmaceutical formulations containing such compounds are also discussed.
    介绍了新型 N-[4-氨基取代)苯基]甲磺酰胺类化合物及其作为心血管药物,特别是作为抗心律失常药物的用途。还讨论了含有此类化合物的药物制剂。
  • LIS, RANDALL;MORGAN, THOMAS K. (JR);MARISCA, ANTHONY J.;GOMEZ, ROBERT P.;+, J. MED. CHEM., 33,(1990) N0, C. 2883-2891
    作者:LIS, RANDALL、MORGAN, THOMAS K. (JR)、MARISCA, ANTHONY J.、GOMEZ, ROBERT P.、+
    DOI:——
    日期:——
  • US4906634A
    申请人:——
    公开号:US4906634A
    公开(公告)日:1990-03-06
查看更多